SUBSCRIBE
SUBSCRIBE
News   Drug Development

Acambis Says Japanese Encephalitis Trial Positive

October 30, 2006 | 
1 min read
LONDON, Oct 30 (Reuters) - UK vaccine maker Acambis said on Monday it had received positive results from a final Phase III safety trial of its experimental vaccine for Japanese encephalitis, and encouraging preliminary efficacy data.
Clinical research Phase 3 Europe
MORE ON THIS TOPIC
Podcast
As FDA Moves Away From Animal Testing, AI and Organoids Can Shine
February 17, 2026
 · 
1 min read
 · 
Jef Akst
stethoscope on glass globe - Usa
FDA
Moderna’s mRNA Vaccine Refusal Comes Amid Global Advanced Therapies Push
February 17, 2026
 · 
5 min read
 · 
Heather McKenzie
A bottle of a vaccine on a reflective surface with the illuminated red outline of the world map in red - 3D render
Vaccines
Moderna’s mRNA Tech Could Boost Flu Shot Efficacy. Americans Will Have To Wait
February 16, 2026
 · 
3 min read
 · 
Annalee Armstrong
Achieve goal concept art collage. Rising arrow chart and halftone hand pointing to center of dartboard. Business goal, achieve targets, success. Trendy modern retro vector illustration
Rare diseases
‘Highly Impressive’ Data Propels BridgeBio’s Achondroplasia Drug Forward
February 12, 2026
 · 
2 min read
 · 
Tristan Manalac